14. 参考文献
1.
2.
3.
4.
5.
6.
7.
8.
平成22年国民生活基礎調査におけるがん検診の受診状況について. 厚生労働省健康局総務課
がん対策推進室. http://www.mhlw.go.jp/stf/houdou/2r9852000001igt0.html.
平成17年度厚生労働省がん研究助成金「がん検診の適切な方法とその評価法の確立に関する
研究」班. 有効性評価に基づく胃がん検診ガイドライン. 2006.
Screening and prevention of gastric cancer. UpToDate. last updated: 6 10, 2013.
坪野吉孝, 久道茂. 症例対照研究による胃がん検診の死亡率減少効果の評価. 日消集検誌, 37
(2):182-185, 1999.
Mizoue T, Yoshimura T, Tokui N, et al. ; Japan Collaborative Cohort Study Group.
Prospective study of screening for stomach cancer in Japan. Int J Cancer. 2003
Aug 10;106(1):103-7.
Riecken B, Pfeiffer R, Ma JL, et al. No impact of repeated endoscopic screens on
gastric cancer mortality in a prospectively followed Chinese population at high risk.
Prev Med. 2002 Jan;34(1):22-8.
Yoshihara M, Hiyama T, Yoshida S, et al. Reduction in gastric cancer mortality by
screening based on serum pepsinogen concentration: a case-control study. Scand
J Gastroenterol. 2007 Jun;42(6):760-4.
Kato M, Asaka M. Recent development of gastric cancer prevention. Jpn J Clin
Oncol. 2012 Nov;42(11):987-94. Epub 2012 Sep 26.
15. 参考文献
9. Fukase K, Kato M, Kikuchi S et al. ; Japan Gast Study Group. Effect of eradication of
Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic
resection of early gastric cancer: an open-label, randomised controlled trial. Lancet.
2008 Aug 2;372(9636):392-7.
10. Wong BC, Lam SK, Wong WM, et al. ; China Gastric Cancer Study Group.
Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of
China: a randomized controlled trial. JAMA. 2004 Jan 14;291(2):187-94.
11. Fuccio L, Zagari RM, Eusebi LH, et al. Meta-analysis: can Helicobacter pylori
eradication treatment reduce the risk for gastric cancer? Ann Intern Med. 2009 Jul
21;151(2):121-8.
12. Ford AC, Moayyedi P. Redundant data in the meta-analysis on Helicobacter pylori
eradication. Ann Intern Med. 2009 Oct 6;151(7):513.